|
Report Date : |
31.12.2014 |
IDENTIFICATION DETAILS
|
Name : |
CHEMICAL-SOLUTION INC. |
|
|
|
|
Registered Office : |
10, Eonju-ro 147-gil, Gangnam-gu, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2014 |
|
|
|
|
Date of Incorporation : |
21.07.2000 |
|
|
|
|
Com. Reg. No.: |
211-86-63287 |
|
|
|
|
Legal Form : |
Co., Ltd by Shares |
|
|
|
|
Line of Business : |
Wholesale of Pharmaceuticals |
|
|
|
|
No. of Employees : |
03 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
Slow but correct |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2014
|
Country Name |
Previous Rating (30.06.2014) |
Current Rating (30.09.2014) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Source
: CIA |
Basic
|
Company Name |
CHEMICAL-SOLUTION INC. (Trade Name : CSI) (Korean Company Name ; “(주)케미칼솔루션”) |
|
Registered
Address |
10, Eonju-ro 147-gil, Gangnam-gu, |
|
Building |
3rd Fl., Yoonoh Bldg. |
|
Zip Code |
135-816 |
|
Tel |
+82-2-543-2822 |
|
Fax |
+82-2-543-2823 |
|
E-mail |
info@chemical-solution.com;david@chemical-solution.com |
|
Website |
www.chemical-solution.com |
|
Trading Address |
3rd Fl., Yoonoh Bldg., 10, Eonju-ro 147-gil, Gangnam-gu, (Old Address System : 3rd Fl., Yoonoh Bldg., 63-19,
Nonhyeon 2-dong, Gangnam-gu, |
|
Tel |
+82-2-543-2822 |
|
Fax |
+82-2-543-2823 |
|
Other Address |
|
|
Tel |
|
|
Fax |
|
|
Type |
Export/Import |
|
Industry |
Data Base Activities and On-line Information Provision
Services |
|
Main Business |
Pharmaceutical Products, Software Development and Supply,
Database, Management Consulting Services |
|
Sub Business |
Wholesale of Pharmaceuticals |
|
Established
(mm/dd/yyyy) |
07/21/2000 |
Detailed Products
|
Activity |
Detailed
Products (UNSPSC) |
|
Sell |
Pharmaceutical Products |
|
Sell |
System Software Development and Supply |
CEO’s
|
Name |
Jo Hyun-Je |
|
Address |
Suite
105-1201, 3, Jamwon-ro 14-gil, Seocho-gu, |
|
Date of Birth |
06/13/1971 |
|
Title |
President
& CEO |
|
Sex |
Male |
|
Nationality |
Korean |
Profiles
|
Capital (KRW) |
650,000,000 |
|
Employees |
3 |
|
Formation |
Co., Ltd by Shares |
|
Bank Details |
Hana
Bank-Eonjuro Branch |
|
Corporate
Registered No. |
110111-2031196 |
|
Business
Registered No. |
211-86-63287 |
|
Permit &
Licenses |
N/A |
|
Shareholder
Position |
N/A |
|
Company
History |
07/21/2000
Incorporated as the present name 09/2001
Designated as a Venture Business 07/2002
Designated as a Promising Export SMEs 02/20/2003
Increased capital to 650,000,000 KRW from 600,000,000 KRW |
|
|
|
Management
|
Job
Description |
Title |
Name |
Sex |
Nationality |
Inauguration
Date |
|
President & CEO |
Mr. |
Jo Hyun-Je |
Male |
Korean |
02/16/2012 |
|
Director |
Mr. |
Jo Bum-Je |
Male |
Korean |
02/16/2012 |
|
Director |
Mr. |
Jung Dae-Hwan |
Male |
Korean |
02/16/2012 |
|
Auditor |
M/S. |
Oh Da-Jung-Yi |
Female |
Korean |
02/19/2009 |
|
Year / Unit :
KRW |
Sales |
Assets |
Net Income |
|
2013 |
7,722,509,000 |
1,348,714,000 |
131,820,000 |
|
2012 |
6,380,820,000 |
1,082,377,000 |
70,968,000 |
|
2011 |
4,999,244,000 |
1,358,913,000 |
109,374,000 |
|
2010 |
3,298,281,000 |
1,639,241,000 |
130,964,000 |
|
2009 |
4,362,000,000 |
1,296,000,000 |
176,000,000 |
|
2008 |
3,176,484,000 |
1,082,809,000 |
119,054,000 |
Financial Description
|
Authorized
Capital(KRW) |
800,000,000 |
|
Paid-Up
Capital(KRW) |
650,000,000 |
|
Total Issued
Shares |
130,000 |
|
Balance Sheet |
|||
|
Unit : Korean Won |
As of
12/31/2013 |
As of
12/31/2012 |
As of
12/31/2011 |
|
Total Assets |
1,348,714,000 |
1,082,377,000 |
1,358,913,000 |
|
Current Assets |
|
|
|
|
-Quick Assets |
|
|
|
|
-Inventories |
|
|
|
|
Fixed Assets |
|
|
|
|
-Investment |
|
|
|
|
-Tangibles |
|
|
|
|
-Intangibles |
|
|
|
|
Total
Liabilities |
520,631,000 |
381,114,000 |
728,619,000 |
|
Current
Liabilities |
|
|
|
|
Fixed
Liabilities |
|
|
|
|
Capital Stock |
650,000,000 |
650,000,000 |
649,999,000 |
|
Capital
Surplus |
|
|
|
|
Profit Surplus |
|
|
|
|
Capital
Adjustment |
|
|
|
|
Total Equity |
828,083,000 |
701,263,000 |
630,294,000 |
|
Liab. &
Shareholder’s Equity |
1,348,714,000 |
1,082,377,000 |
1,358,913,000 |
|
Income Statement |
|||
|
Unit : Korean
Won |
As of
12/31/2013 |
As of
12/31/2012 |
As of
12/31/2011 |
|
Sales |
7,722,509,000 |
6,380,820,000 |
4,999,244,000 |
|
Cost of Sold
Goods |
|
|
|
|
Gross Profit |
|
|
|
|
Selling &
Admin. Expenses |
|
|
|
|
Operating
Income |
117,794,000 |
95,500,000 |
129,950,000 |
|
Non-Operating
Income |
|
|
|
|
Non-Operating
Expenses |
|
|
|
|
Income Before
Taxes |
|
|
|
|
Income Taxes
Expenses |
|
|
|
|
Net Income |
131,820,000 |
70,968,000 |
109,374,000 |
Products,
Technologies, Services Description
|
Main Products
& Services |
Pharmaceutical Products, Software Development and Supply,
Database, Management Consulting Services |
|
Detailed
Products Spec. |
|
|
Technologies
Acquired |
|
Sales by Region
(Activity & Markets)
Not Available.
Court Action
Not Available.
--
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.75 |
|
|
1 |
Rs.99.88 |
|
Euro |
1 |
Rs.77.32 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
|
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.